Munich, Re’s

Munich Re’s Strategic Squeeze: Record Profits, Shrinking Volumes, and a €900 Million Bet on Itself

18.05.2026 - 10:21:40 | boerse-global.de

Munich Re's Q1 net profit jumped 57% to €1.714B, driven by stellar underwriting, but currency effects and deliberate volume decline keep stock within 2% of 52-week low. Company launches €2.25B buyback.

Munich Re’s Strategic Squeeze: Record Profits, Shrinking Volumes, and a €900 Million Bet on Itself - Foto: über boerse-global.de
Munich Re’s Strategic Squeeze: Record Profits, Shrinking Volumes, and a €900 Million Bet on Itself - Foto: über boerse-global.de

Munich Re turned in a blockbuster first quarter, yet its stock is barely clinging to levels seen during last year’s trough. The disconnect between a 57% profit surge and a share price within 2% of its 52-week low highlights the competing forces at work: stellar underwriting discipline versus punishing currency headwinds, and a deliberate volume contraction that has left the market cold.

Net profit for the three months ended March 2026 reached €1.714 billion, up from roughly €1 billion a year earlier. The primary driver was the property and casualty reinsurance segment, where large-loss expenses collapsed to just €130 million. In the prior-year period, the Los Angeles wildfires alone had carved a deep dent into earnings. The combined ratio in that unit improved to a sparkling 66.8%, well ahead of analyst expectations.

That operating strength, however, was barely visible in the top line. Gross premiums written slipped to around €15 billion, clipped by €162 million in negative foreign exchange effects. The dollar – a currency in which Munich Re books a significant chunk of its business – has been the prime culprit. At the start of 2025 the euro bought roughly $1.03; by the first quarter of 2026 the exchange rate had swung to a range of $1.15 to $1.20, squeezing euro-denominated premium and profit figures alike. On a constant-currency basis the revenue picture would look far healthier, but reported numbers tell a bleaker story.

Management is responding with a calculated trade-off: volume for margin. At the April renewal season, Munich Re allowed its written volume to fall 18.5% and accepted a 3.1% decline in risk-adjusted pricing. The company simply refused to renew contracts that failed to meet its minimum return thresholds. That pricing discipline protects portfolio quality but comes at the cost of growth – and the stock market has taken note. Since the start of 2026 the shares have dropped 13.46%, and over the past twelve months the decline stands at 17.80%.

Should investors sell immediately? Or is it worth buying MĂĽnchener RĂĽck?

Against that backdrop, Munich Re has launched a fresh buyback program. The first tranche, valued at up to €900 million, began on May 14 and runs through August 21, 2026. The overall authorization totals €2.25 billion and will remain in effect until the annual general meeting scheduled for April 29, 2027. All repurchased shares are slated for cancellation. The move signals boardroom confidence in the company’s intrinsic value even as the stock languishes: on Friday the shares closed at €475.10, a mere 1.67% above the 52-week low and well below both the 50-day moving average and the 200-day line.

The technical picture remains damaged. The stock’s distance from its 200-day average is roughly 12%, and the short-term trend offers little reprieve. Analysts note that until revenue stabilises – and in particular until the euro-dollar exchange rate stops eating into reported earnings – the market is unlikely to reward the bottom-line strength.

The company is also attacking costs on another front. At its Ergo primary insurance unit, Munich Re plans to eliminate roughly 1,000 positions by 2030, mostly through attrition in Germany, where about 200 jobs will disappear annually. No compulsory redundancies are expected. The restructuring is meant to generate recurring savings of around €600 million per year by the end of the decade, with €200 million already targeted for 2026.

MĂĽnchener RĂĽck at a turning point? This analysis reveals what investors need to know now.

Management nonetheless holds firm on its full-year net profit guidance of €6.3 billion and its long-term return-on-equity target of more than 18%. The capital base provides ample room for manoeuvre: the Solvency II ratio stands at 292%, even after backing out the latest buyback tranche.

The next major test comes in July, when another renewal window opens. Munich Re expects pricing to remain broadly stable. If that holds, some of the current market scepticism around growth could ease. If the dollar strengthens further against the euro, however, the pressure on reported results will only intensify. For now, the equation is simple: Munich Re is earning more than ever, but the market is not convinced those earnings are worth what the stock says they are.

Ad

MĂĽnchener RĂĽck Stock: New Analysis - 18 May

Fresh MĂĽnchener RĂĽck information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated MĂĽnchener RĂĽck analysis...

So schätzen die Börsenprofis Munich Aktien ein!

<b>So schätzen die Börsenprofis  Munich Aktien ein!</b>
Seit 2005 liefert der Börsenbrief trading-notes verlässliche Anlage-Empfehlungen – dreimal pro Woche, direkt ins Postfach. 100% kostenlos. 100% Expertenwissen. Trage einfach deine E-Mail Adresse ein und verpasse ab heute keine Top-Chance mehr. Jetzt abonnieren.
FĂĽr. Immer. Kostenlos.
en | DE0008430026 | MUNICH | boerse | 69364332 |